speb/financial-data huggingface dataset:
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 718000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 19763000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 228000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 185000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 201000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1679000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3855000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 135000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 7476000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Other Special Charges: -313000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Payables: 3921000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 1670000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4658000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 207000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 316909016.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 313000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 20080000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 17612000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 85465868.26
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 456000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 32000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 31769000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 20121000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 5276000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 20080000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 8488000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 11689000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 9275000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1063000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 188000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 313000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 313000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 1207238.00
ELGIEQUIP.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 11868000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3860000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 10034000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 316000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 3.01
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4948000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 213000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 213000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 317000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.01
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — EBIT: 1339000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1552000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 5086000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 50000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 50000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Income: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 952000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -50000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -50000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1702000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 1062783553.14
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1226000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 10034000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -68000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1707000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: 150000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 1289000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4948000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 213000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -150000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -39216446.86
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 337000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 8808000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -150000000.00
ELGIEQUIP.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -150000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — +Operating Expense: 14602000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 4046000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — +Total Revenue: 39295000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 11126000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 4596000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4596000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 7239000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 7239000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -5553000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -5553000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 251000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 251000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -327000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -327000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Amortization: 65000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 0.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 1242000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 1242000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 315240000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 315000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Basic EPS: 13.65
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 4.06
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1203000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 2832000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 2832000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1544000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1283000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1283000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 317000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 317000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1635000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1635000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9247000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 9247000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -694000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 144000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 144000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 1491000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1491000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1022000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 50000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 138000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Change In Payable: 1229000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1185000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -624000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 432000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Common Stock: 317000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 317000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 22319000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 22319000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 42000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Common Stock Payments: -261000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 1465000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 1465000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 19669000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 5588000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Current Assets: 24902000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 24902000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 391000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 391000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Current Debt: 4048000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 4048000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 4439000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4439000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 11959000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 11959000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 715000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 715000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Depreciation: 858000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 858000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 858000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 250000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 793000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 250000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 316120000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 316000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Diluted EPS: 13.61
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 4.05
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1280000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 13000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 13000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 39000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — EBIT: 6028000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — EBIT: 1699000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — EBITDA: 6886000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — EBITDA: 1949000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1635000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 50000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 50000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -3120000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 4131000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4131000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 2991000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -671000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -393000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 954000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Goodwill: 2388000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 2388000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2604000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2604000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 7566000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 7566000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 11361000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 11361000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Gross Profit: 19626000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 5538000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 0.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 0.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Interest Expense: 254000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 61000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 254000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 61000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Interest Income: 593000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 593000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -258000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 650000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Inventory: 7107000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 7107000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 26367000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 26367000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -983000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 43000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 43000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1242000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1242000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 42000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 927000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 927000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 892000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 892000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 892000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 892000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -138000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 196000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 196000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 6116000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 6116000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Minority Interests: 0.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 13000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: -219000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2413000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2413000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 757000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Income: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Income: 1280000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1280000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1280000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1280000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1280000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 5774000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 4302000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1280000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Interest Income: 298000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -61000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -615000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -1653000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -138000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 298000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -61000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Net PPE: 5808000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 5808000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1054000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -1515000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 19715000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 19715000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 438000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 438000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 75000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 75000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 206000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 206000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 100000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 100000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 6613000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1949000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Normalized Income: 4098597506.06
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 1280000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 4535000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Operating Income: 5024000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Operating Income: 1492000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Operating Revenue: 39295000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 11126000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 315241478.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 315241478.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 60000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 60000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 22000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 22000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 111000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 111000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 216000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 216000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 68000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 68000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 254000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -50000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -50000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 35000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 222000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 4394000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1781000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Payable: 1102000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 1102000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Properties: 21000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 21000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 299000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 299000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 7612000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 7612000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Other Special Charges: -243000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Payables: 5789000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Payables: 5789000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 851000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 851000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Pretax Income: 5774000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 1638000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 47000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -799000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1544000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 2288000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2288000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 19669000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5588000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 858000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 250000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 134000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 134000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -138000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -261000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Research And Development: 51000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 99000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 99000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 20424000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 20424000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 13000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 184000000.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 490000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 384000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 1338000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Share Issued: 316909016.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 316909016.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Special Income Charges: 196000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 78000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 22319000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 22319000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 19715000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 19715000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 69597506.06
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Tax Provision: 1472000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 358000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.25
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
ELGIEQUIP.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1496000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Assets: 35455000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 35455000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 22319000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 22319000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Debt: 5331000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 5331000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 22319000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 22319000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Total Expenses: 34271000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 9634000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 13136000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 13136000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 10553000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 10553000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1177000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1177000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 41000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 78000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 78000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 273000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 273000000.00
ELGIEQUIP.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 1667538.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 1667538.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Treasury Stock: 860000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 860000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Work In Process: 620000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 620000000.00
ELGIEQUIP.NS balance_sheet (annual, 2026-03-31) — Working Capital: 12943000000.00
ELGIEQUIP.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 12943000000.00
ELGIEQUIP.NS income_statement (annual, 2026-03-31) — Write Off: 47000000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1850720000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — +Total Revenue: 3871540000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 565330000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 734110000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1264510000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1900000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -67800000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Amortization: 1130000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1130000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 214010000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 50050000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Basic EPS: -3.27
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 100770000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1230710000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -122510000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 6190000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 50050000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 43600000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 43600000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -350000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 43600000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Change In Inventory: 102570000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -25290000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Change In Payable: 122740000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -195160000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: 14990000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Changes In Cash: -57170000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Common Stock: 50050000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 1714570000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 210170000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 2139910000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Current Assets: 2177170000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 3650000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Current Debt: 1832280000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 1835930000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 2648920000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 9640000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Depreciation: 179470000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 180600000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 180600000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 179470000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 50050000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Diluted EPS: -3.27
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -163520000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 920000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 530000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — EBIT: -9770000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — EBITDA: 170830000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — End Cash Position: 43600000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 186690000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -120680000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 406190000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 35460000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -60180000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -240000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 95500000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Goodwill: 130350000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 142530000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 801910000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 3338610000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Gross Profit: 1731630000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 0.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Interest Expense: 146130000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 146130000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Interest Income: 14690000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 14690000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -153970000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 15440000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Inventory: 995500000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 4182120000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -94460000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 186690000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 441760000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 2540000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 635270000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 637810000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1493310000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Net Debt: 2423950000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 42310000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income: -163520000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -163520000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -163520000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -163520000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -163520000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -155900000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -163520000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Interest Income: -141570000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 11280000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 38630000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -203150000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -141570000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -350000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Net PPE: 2074100000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -121710000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 241780000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 1572040000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 289960000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 70210000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 193350000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Normalized Income: -147756000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 157970000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Operating Income: -119090000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Operating Revenue: 3871540000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 50050000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 55370000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 238025000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 1555667000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 12180000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 40040000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 141560000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 24280000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 10000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 87290000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 571440000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 155970000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Properties: 5550000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 19540000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 203990000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Other Special Charges: -410000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Payables: 722220000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 118240000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Pretax Income: -155900000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -90000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -122510000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 461160000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 2139910000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 180600000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 14830000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 14830000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 203990000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -385160000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 800000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 255700000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 351200000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Share Issued: 50050000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Special Income Charges: -82170000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 1714570000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 1572040000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -6756000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Tax Provision: 7620000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.30
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 20430000.00
ELGIRUBCO.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -5080000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Assets: 5001300000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 2349840000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Debt: 2473740000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 1714570000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Total Expenses: 3990630000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 3286730000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2824110000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 637810000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 10130000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -22520000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -22520000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 88110000.00
ELGIRUBCO.NS balance_sheet (annual, 2022-03-31) — Working Capital: -471750000.00
ELGIRUBCO.NS income_statement (annual, 2022-03-31) — Write Off: 82580000.00
ELGIRUBCO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1996140000.00
ELGIRUBCO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 3927460000.00
ELGIRUBCO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 446360000.00
ELGIRUBCO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 674160000.00
ELGIRUBCO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1677920000.00
ELGIRUBCO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1900000.00
ELGIRUBCO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -68970000.00
ELGIRUBCO.NS income_statement (annual, 2023-03-31) — Amortization: 10000.00
ELGIRUBCO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 10000.00
ELGIRUBCO.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 0.00